Navigation Links
Scientists discover new genetic subtypes of common blood cancer

Scientists at Dana-Farber Cancer Institute and collaborators have identified four distinct genetic subtypes of multiple myeloma, a deadly blood cancer, that have different prognoses and might be treated most effectively with drugs specifically targeted to those subtypes.

A new computational tool based on an algorithm designed to recognize human faces plucked the four distinguishing gene patterns out of a landscape of many DNA alterations in the myeloma genome, the researchers report in the April issue of Cancer Cell.

These results "define new disease subgroups of multiple myeloma that can be correlated with different clinical outcomes," wrote the authors, led by Ronald DePinho, MD, director of Dana-Farber's Center for Applied Cancer Science.

Not only do the findings pave the way for treatments tailored to a patient's specific form of the disease, they also narrow down areas of the chromosomes in myeloma cells likely to contain undiscovered genetic flaws that drive myeloma, and which might turn out to be vulnerable to targeted designer drugs.

Kenneth Anderson, MD, medical director of the Jerome Lipper Multiple Myeloma Center at Dana-Farber and an author of the paper, said the findings "allow us to predict how patients will respond to current treatments based on a genetic analysis of their disease." In addition, the findings "identify many new genes implicated in the cause and progression of myeloma, and the product of those genes can be targeted with novel therapies."

Multiple myeloma, the second most common blood cancer after non-Hodgkin's lymphoma, is incurable, although some patients live for a number of years following diagnosis. About 50,000 people in the United States are living with the disease, and an estimated 16,000 new cases are diagnosed annually. Despite improvements in therapy, the five-year survival rate in multiple myeloma is only 32 percent and durable responses are rare.

The new report emerged from a co
'"/>

Source:Dana-Farber Cancer Institute


Page: 1 2 3

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding
Post Your Comments:
(Date:12/3/2009)... a personality change in warmer water, according to an intriguing ... more aggressive. , Experiments with two species of young damselfish ... time that some reef fish are either consistently timid, or ... marked as water temperatures rise. , A slight lift of ...
(Date:12/3/2009)... world when it comes to investment in energy efficient ... (EPSRC) Chief Executive Dave Delpy believes that more is ... fuel cells, marine, wind and solar power solutions, but ... different solutions if we are to meet our carbon ...
(Date:12/2/2009)... PHILADELPHIA Less acculturated Latino men have a more ... acculturated to U.S. culture, but acculturation has no affect ... findings are published in Cancer Epidemiology, Biomarkers & ... Cancer Research. The December issue has a special focus ...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2Sarnova Names Hank Struik Chief Executive Officer 48162 1Sarnova Names Hank Struik Chief Executive Officer 48162 2Sarnova Names Hank Struik Chief Executive Officer 48162 3AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 1AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 1RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 3RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 4RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 5RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 6
... reveals that doctors treating life-threatening emergencies such as allergy attacks ... confusing labelling. , Adrenaline is stored in salt water in ... needed. The amount of adrenaline contained in the ampoule ... the drug per 1 mL of salt water) and a ...
... 28, 2007) -- For patients with hepatitis C, having ... associated with advanced disease. This problem is compounded by ... can further reduce platelet numbers to dangerously low levels, ... Now, research published in the New England Journal of ...
... Since the findings from the Human Genome Project and other ... been an enormous amount of research producing powerful evidence of ... explores some of the many relics of evolution found in ... OF EDEN: THE POWERFUL EVIDENCE OF EVOLUTION IN HUMAN DNA ...
Other Biology News:Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 3There is powerful evidence of evolution in human DNA 2
(Date:12/2/2009)... Steel is emerging as one of the fastest growing green ... Green Energy Group and True Green Planet,s President and Recycling ... for over 25 years, stated that Spectrum Blue Steel is ... for spectacular earnings because of the bi products recovered by ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Drug Discovery Technologies - ... Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, ... ongoing element of every pharmaceutical company,s business ...
(Date:12/2/2009)... Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... a dose confirmation and dosimetry trial of Cotara® in ... of brain cancer. Cotara is a targeted monoclonal ... potential new treatment for GBM. Cotara specifically targets ...
(Date:12/2/2009)... NV,the Netherlands based biotechnology company focusing on protein mimicking,technology ... it,has appointed Wim E.M. Mol, Ph.D. as new Chief ... will be responsible for all of Pepscans corporate functions ... He brings to,Pepscan more than 20 years of management ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2
... 20 Vical Incorporated,(Nasdaq: VICL ) today ... appointment of Andrew R. de Guttadauro as Vice ... de Guttadauro was Senior Director of,Strategy at Biogen ... the commercial development of that company,s Zevalin,the first ...
... Yang Mulia Pangkuan Negeri -, TORONTO, Aug. ... focused on developing simple blood-based biomarker tests for ... today,announced that its co-founder and Chief Scientific Officer, ... Pangkuan Negeri (DMPN), a State Honour,given by the ...
... Space, Poised for Market Launch, KIRKLAND, Wash., Aug. ... devices for the treatment of arterial,disease, today announced that ... and has started building its sales team in preparation ... System. Recently Pathway moved from its old 10,000-square-foot ...
Other Biology Technology:Vical Names Andrew de Guttadauro Vice President, Corporate Development 2Vical Names Andrew de Guttadauro Vice President, Corporate Development 3GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia 2Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth 2
Mouse Ameloblastin Biotinylated Affinity Purified PAb ENTREZ GeneID: 11698...
... to GRASP1 ( Abpromise for ... Antigen: Synthetic peptide corresponding to ... terminal region of rat GRASP1, conjugated ... Entrez GeneID: 56850 ...
Prepared from plasminogen by activation with immobilized human uPA...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Biology Products: